Pharmafile Logo
Pharmafocus logo
Advanced Search

2010 pharma results

Showing 10 posts of 10 posts found.

Bayer's Marijn Dekkers

Bayer goes for pharma growth

March 1, 2011
Research and Development, Sales and Marketing 2010 pharma results, Bayer, Dr Jörg Reinhardt, Marijn Dekkers, Nexavar, VEGF Trap-Eye, Xarelto

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …

Feature
Merck KGaA

Merck KGaA sales soar

February 21, 2011
Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro

Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …

News

Shire thrives on specialist portfolio

February 11, 2011
Sales and Marketing 2010 pharma results, ADHD, Shire, Vyvanse

Speciality pharma company Shire has posted sales growth of 16%, led by its ADHD treatment Vyvanse. Sales of Vyvanse rose …

News

Generics force Sanofi into standstill

February 9, 2011
Sales and Marketing 2010 pharma results, Jevtana, Multaq, Sanofi, Sanofi-Aventis, generics

An onslaught of generic competition combined with healthcare cuts in the US and Europe meant Sanofi-Aventis’ revenues were brought to …

News

Teva surges ahead

February 9, 2011
Sales and Marketing 2010 pharma results, Copaxone, Teva, Teva Pharmaceutical

Generics giant Teva enjoyed a strong year of growth in 2010, lifted by the acquisition of Ratiopharm, patent expiries of …

News

GSK profits slump amid ongoing Avandia woes

February 7, 2011
Sales and Marketing 2010 pharma results, Avandia, GSK, GlaxoSmithKline

GlaxoSmithKline’s ongoing woes with diabetes drug Avandia hit profits in 2010. Profits after tax plummeted 56% to £3 billion for …

News

Merck dipped into the red as 2010 ended

February 4, 2011
Sales and Marketing 2010 pharma results, Merck & Co

Merck & Co made a $531 million loss in the final quarter of 2010 – down from a profit of …

News
Roche Severin Schwann

Roche weathers tough year and looks to pipeline for 2011

February 3, 2011
Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab

Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …

News

Novartis posts strong growth but warns of tough year ahead

January 27, 2011
Sales and Marketing 2010 pharma results, Novartis

Novartis has posted strong sales growth for the full year but its chief executive warns of ‘headwinds in 2011’ as …

News

J&J posts negative growth as pharma sales stall

January 26, 2011
Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta

Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025